Cardiovascular

Risk factor profiles and visual outcomes of non-arteritic anterior ischemic optic neuropathy in younger Chinese patients.

TL;DR

Younger and older NAION patients exhibit distinct risk profiles and visual field defect patterns, and while younger patients demonstrated significant within-group visual improvement, only the change in mean deviation differed significantly between groups, necessitating cautious interpretation of age-related recovery differences.

Key Findings

The young NAION group (age <50) included more males, had higher smoking rates, and fewer bilateral cases compared to the older comparison cohort.

  • Young group: n=102 (age <50 years); older comparison group: n=111 (age ≥50 years)
  • All three differences (sex distribution, smoking rates, bilateral cases) reached statistical significance at P<0.05
  • The older comparison group comprised consecutively enrolled cases within a predefined study period (May 2022–February 2026) rather than a random sample of all eligible older NAION patients
  • Single-center retrospective cohort study design with 6-month follow-up for all patients

The older comparison cohort had a higher prevalence of hypertension, cardiovascular disease, and peripapillary hyperreflective ovoid mass-like structure (PHOMS) compared to younger patients.

  • All three differences reached statistical significance at P<0.05
  • PHOMS is an ocular structural abnormality detected on imaging
  • Systemic vascular diseases were identified as the main risk factors in elderly patients, whereas ocular structural abnormalities may be associated with early-onset NAION

Inferior hemifield visual field defects predominated in young NAION patients, whereas diffuse defects were more common in the older comparison cohort.

  • Visual field patterns differed between the two age groups
  • Visual field index (VFI), mean deviation (MD), and pattern standard deviation (PSD) were among the outcome measures collected
  • The difference in visual field defect pattern represents a distinct clinical presentation between age groups

Significant within-group improvements in best-corrected visual acuity (BCVA), visual field index (VFI), mean deviation (MD), and pattern standard deviation (PSD) were observed only in the young group over 6 months.

  • All within-group improvements in the young group reached significance at P<0.01
  • No significant within-group improvements in these measures were observed in the older comparison cohort
  • Between-group differences in improvement reached significance only for MD
  • The authors note this necessitates cautious interpretation of age-related recovery differences

Multivariable analysis identified younger age, shorter onset-to-presentation time, and better baseline BCVA as factors associated with greater BCVA recovery.

  • Analysis used a hybrid selection strategy combining mandatory clinical covariates plus univariate screening
  • The authors caution that these associations should be interpreted cautiously given study limitations
  • Multivariable linear regression was the statistical method used to identify independent predictors of visual recovery
  • All patients underwent standardized 6-month follow-up with collection of BCVA, VFI, MD, and PSD

What This Means

This research suggests that non-arteritic anterior ischemic optic neuropathy (NAION), a condition where the optic nerve loses its blood supply and vision is damaged, presents differently in younger patients (under 50) compared to older patients. In this Chinese hospital-based study of 213 NAION patients followed for six months, younger patients were more likely to be male smokers with vision loss limited to one eye, while older patients more commonly had high blood pressure, cardiovascular disease, and a specific structural eye abnormality called PHOMS. The type of vision loss also differed: younger patients tended to lose vision in the lower half of their visual field, while older patients more often experienced diffuse (widespread) vision loss. This research also suggests that younger NAION patients showed measurable improvements in vision and visual field over the six-month follow-up period, while the older comparison group did not show statistically significant improvements in the same measures. However, when the two groups were compared directly, only one measure—mean deviation, a summary score of visual field loss—showed a statistically significant difference in improvement between the groups. The study also found that being younger, seeking treatment sooner after symptom onset, and having better vision at the initial visit were all linked to better visual recovery. These findings matter because they highlight that NAION is not a one-size-fits-all disease: the risk factors, visual field patterns, and potential for recovery appear to differ meaningfully by age. This could have implications for how doctors counsel and monitor younger versus older NAION patients. However, the authors emphasize caution in interpreting the results, as this was a single-center retrospective study with a comparison group that was not randomly selected, which limits how broadly the findings can be applied.

Have a question about this study?

Citation

Zhang C, Li J, Han B, Xu W, Wang Q, Yu G. (2026). Risk factor profiles and visual outcomes of non-arteritic anterior ischemic optic neuropathy in younger Chinese patients.. BMC ophthalmology. https://doi.org/10.1186/s12886-026-05272-z